Cerner Provides Access to De-Identified Patient Data for COVID-19 Research and Vaccine Development
April 24 2020 - 9:19AM
Cerner Corporation (Nasdaq: CERN), a global health care technology
company, is now offering select U.S. health systems and academic
research centers complimentary access to critical de-identified
COVID-19 patient data to help fight the pandemic. This offering
will provide eligible health care researchers free access to
Cerner’s COVID-19 data set to support epidemiological studies,
clinical trials and medical treatments related to COVID-19, in line
with applicable laws and guidelines.
The de-identified patient data secured and stored on Cerner
HealtheDataLab™, powered by Amazon Web Services Inc. (AWS), will
include COVID-19-related demographics to help track spread and
surge, underlying illnesses and chronic conditions, treatments, lab
results and clinical complications and outcomes that could help
drive important medical decisions. A committee including Cerner
associates and industry advisors will review the applications and
identify recipients that will benefit from the complimentary
offering.
“Cerner believes deeply in the power of clinical data to advance
global research,” said Donald Trigg, president, Cerner. “The
current COVID-19 pandemic compelled our team to develop a strategy
to help leading health systems advance the search for critical
solutions. When we ultimately move from crisis response to
recovery, I am hopeful it will also demonstrate the promise of a
‘learning heath network’ to accelerate the next generation of
discovery.”
Cerner and AWS’ collaboration continues to focus on making
health care better for patients and providers. Last year, Cerner
worked to reduce re-admissions to hospitals leveraging
de-identified data to help make early determinations of the cause
of return hospitalizations using AWS services.
“This is a pivotal moment in time when having access to the
right information at the right time can help save lives,” Shez
Partovi, MD, director of Worldwide Business Development for
Healthcare, Life Sciences, and Genomics, Amazon Web Services, Inc.
“By supporting complimentary access to Cerner HealtheDataLab there
is an opportunity to bring health systems, academic medical centers
and technology efforts together to securely share information and
approaches to better understand, combat and contain COVID-19.”
Prior to COVID-19, Cerner began working with research
institutions to help clinicians more easily and efficiently gain
health insights and guide care. Last year, Cerner announced the
development of the Cerner Learning Health NetworkSM , piloting the
program with Duke Clinical Research Institute. This work helps
automate data collection from multiple sources, including the
electronic health record (EHR), to rapidly give medical researchers
secure and compliant access to important information that has the
potential to transform patient care. “This opportunity with Cerner
is an important example of how access to open science benefits the
needs of providers, patients and communities,” said Eric Peterson,
MD, Duke Clinical Research Institute, strategic adviser, Cerner.
“By harnessing the power of these data sets, researchers can
quickly, securely and freely answer scientific questions about this
pandemic.”
Amid COVID-19, Cerner has taken steps to enhance and introduce
new technology offerings and recommendations to support health
systems as they fight the pandemic, waive license fees for
expansion of hospital beds, establish new dashboards designed to
summarize and display trends, among other community support efforts
globally. Cerner has also launched a dedicated resource site giving
clients access to new and updated offerings. More information on
clinical research can be accessed at Cerner.com.
About CernerCerner’s health technologies
connect people and information systems in thousands of contracted
provider facilities worldwide dedicated to creating smarter and
better care for individuals and communities. Recognized globally
for innovation, Cerner assists clinicians in making care decisions
and assists organizations in managing the health of their
populations. The company also offers an integrated clinical and
financial system to help manage day-to-day revenue functions, as
well as a wide range of services to support clinical, financial and
operational needs, focused on people. For more information,
visit Cerner.com, The Cerner Blog or connect
on Facebook, Instagram, LinkedIn, Twitter or The
Cerner Podcast. Nasdaq: CERN. Health care is too
important to stay the same.
Media Contacts:CernerMisti
Preston, Director of Public Relations,
MediaRelations@cerner.com
Cerner (NASDAQ:CERN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cerner (NASDAQ:CERN)
Historical Stock Chart
From Sep 2023 to Sep 2024